Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates

Go back to Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
(NASDAQ: AUTL) Delayed: 2.03 -0.08 (3.79%)
Previous Close $2.11    52 Week High
Open $2.10    52 Week Low
Day High $2.10    P/E N/A 
Day Low $2.02    EPS
Volume 1,715,650